Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Respiratory Syncytial Virus (RSV) attachment glycoprotein G, subtype A, is a major surface protein of RSV that mediates initial attachment of the virus to host cell membranes. It interacts with cellular receptors such as heparan sulfate proteoglycans (HSPG) or CX3CR1. It also modulates the immune response. It is a target for vaccine development and antibody characterization.
Attachment to host cell receptors (Heparan sulfate proteoglycans (HSPG) or CX3CR1) to mediate viral entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory Syncytial Virus (RSV) attachment glycoprotein G, subtype A (RSV-A G protein).